Skip to main content
. 2020 Feb 27;12(3):550. doi: 10.3390/cancers12030550

Table 4.

The comparison of the colon cancer incidence densities between gallbladder stones patients with and without cholecystectomy, stratified by sex, location of cancer, and follow-up duration.

Outcome Cholecystectomy Crude HR
(95% CI)
Adjusted HR §
(95% CI)
Yes No
Event Rate # Event Rate #
Follow-Up Period ≤ 6 Months
All
Proximal colon cancer 90 2.21 9 0.22 10.1 (5.09, 20.0) *** 10.4 (5.23, 25.6) ***
Distal colon cancer 52 1.27 7 0.17 7.51 (3.41, 16.5) *** 7.70 (3.50, 17.0) ***
Rectal cancer 102 2.50 13 0.31 7.93 (4.45, 14.1) *** 8.06 (4.53, 14.4) ***
Female
Proximal colon cancer 49 2.61 4 0.21 12.4 (4.48, 34.4) *** 13.0 (4.69, 36.0) ***
Distal colon cancer 22 1.17 3 0.16 7.43 (2.23, 24.8) *** 7.73 (2.31, 25.8) ***
Rectal cancer 43 2.29 2 0.10 21.8 (5.28, 89.9) *** 22.5 (5.46, 93.0) ***
Male
Proximal colon cancer 44 2.00 9 0.40 4.94 (2.41, 10.1) *** 4.99 (2.44, 10.2) ***
Distal colon cancer 37 1.68 27 1.20 1.40 (0.85, 2.29) 1.42 (0.86, 2.33)
Rectal cancer 81 3.68 42 1.87 1.96 (1.35, 2.85) *** 2.00 (1.38, 2.91) ***
Follow-Up Period > 6 Months
All
Proximal colon cancer 70 0.17 121 0.23 0.77 (0.57, 1.03) 0.72 (0.54, 0.97) *
Distal colon cancer 93 0.22 173 0.33 0.70 (0.55, 0.90) ** 0.65 (0.51, 0.84) ***
Rectal cancer 149 0.35 289 0.55 0.66 (0.54, 0.81) *** 0.63 (0.51, 0.77) ***
Female
Proximal colon cancer 35 0.17 59 0.22 0.82 (0.54, 1.24) 0.76 (0.50, 1.15)
Distal colon cancer 32 0.16 62 0.24 0.70 (0.46, 1.08) 0.66 (0.43, 1.02)
Rectal cancer 56 0.28 116 0.44 0.67 (0.48, 0.92) * 0.64 (0.46, 0.88) **
Male
Proximal colon cancer 32 0.14 58 0.22 0.71 (0.46, 1.10) 0.68 (0.44, 1.04)
Distal colon cancer 54 0.24 88 0.33 0.79 (0.56, 1.11) 0.73 (0.52, 1.03)
Rectal cancer 71 0.32 142 0.53 0.63 (0.47, 0.84) ** 0.59 (0.44, 0.79) ***

PY, person-years; Rate #, incidence rate per 1000 person-years. Crude HR, relative hazard ratio. Only those found to be significant in the univariable analysis were further examined in the multivariable analysis. Adjusted HR § multivariable analysis including age, gender, and comorbidities. * p < 0.05, ** p < 0.01, *** p < 0.001.